Diamond Biotechnology Co., Ltd

NT$19.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6815Healthcare
Country Taiwan
PE (Fwd) •••
TSR 6Y CAGR (13.94%)
Div yield 0.88%
ROE (7.98%)
Medical Devices
Beta (5Y) 0.34
PE TTM —
TSR TTM (72.86%)
Mkt cap NT$754.4M
ROIC (10.28%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$24
26.27%
(55.95%)
Hold 0|1|1|9|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.24
0.23
0.24
0.26
23.68%
10.76%
4.73%
4.27%
RevenueNT$M
37.94
39.95
39.56
40.23
(1.16%)
2.00%
2.55%
4.26%
Peers (US$22.90M)
Cap (US$)
PE
23.67M
7.249x
Capital
TTM
5Y
10Y
Leveragex
1.507
0.144
0.135
EBIT/Intx
0.392
0.635
0.660
Own earn%
86.86
214.75
125.85
Sh yield%
13.38
54.62
55.58
Owners
Insiders/Inst%
2.26
59.11
Short interest%
4.08
SBC / revenue%
2.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
11–21
$1 testx
—
Incr. ROIC%
9